UK +44 (0)1865 849841
Malaysia +60 3 2117 5193

Biologics Congress Europe – Slide release

Presented at the 4th Biologics & Biosimilars Congress, these free slides are now available to download and share with your colleagues.

Strategies for Coping with the Evolving Landscape of Biosimilars Patent Resolution in the United States
 Strategies coping evolving landscape biosimilars patent resolution united states The United States passed the Biologics Price Competition and Innovation Act (“BPCIA”) in 2009 to bring biosimilar drug products to market. Here Andrew W. Williams from McDonnell Boehnen Hulbert & Berghoff discusses patent issues, price competition and provides guidelines for biosimilar applicants.

View the slides

The Journey to “The” Antibody: Accessing a Versatile Toolbox
Journey Antinbody Accessing Versatile Toolbox Triple Vector allows work to flow straightforward from research directly into mammalian expression in full therapeutic format eliminating the need to change the backbone of the plasmid thus saving much time and money.

View the slides

Global Legal Issues Associated with Biosimilars
Global Legal Issues Associated Biosimilars This presentation focuses on: The current state of biosimilars globally, regulatory issues, patent challenges faced by companies, ways to minimize risk and high level review of patent litigation worldwide.

View the slides                                                          

Want to read more on Biologics? Why not click here to see our latest blog post?

Leave a Reply

Subscribe to Our Newsletter

Get free reports and resources from our world class speakers.
  • This field is for validation purposes and should be left unchanged.

Life Sciences Twitter Feed

Archive